Research on the Evaluation of Technological Innovation Capability of China’s Biopharmaceutical Industry
- 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
- 2 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
Abstract
Objective: To analyze the innovation capability of China ’ s biopharmaceutical industry to explore ways to enhance innovation capability. Methods: This paper firstly constructs an evaluation system of technological innovation capability of biopharmaceutical industry based on the summary of previous research. The biopharmaceutical industry data from 2014 to 2019 were used to analyze the technological innovation capacity of biopharmaceutical industry in each province and city by using factor analysis and SPSS24.0 software. Results: The top three technological innovation capacity scores of provinces and cities in 2014-2019 are Jiangsu, Shandong and Zhejiang, with 1.95, 1.62 and 1.10 respectively. Conclusion: Provinces and cities with high innovation capacity are generally concentrated in the coastal area of East China, forming a high-quality innovation region with Jiangsu, Zhejiang and Guangdong as typical representatives.
- Cheng, Y., Yang, L., & Shan, L. Q. (2020). Research on the Innovation Capability of Pharmaceutical Manufacturing Industry in Jiangsu Province. Modern Trade Industry, 41, 1-3. https://doi.org/10.19311/j.cnki.1672-3198.2020.31.001
- Gao, X. N., Ou, G. J., & Cai, S. S. (2018). Research on the Evaluation and Improvement Path of Innovation Efficiency of Biopharmaceutical Industry—Taking Hubei Province as an Example. Science and Technology Management Research, 38, 75-80.
- Lai, M. L., Xu, N., & Ge, F. L. (2020). Research on Technological Innovation Efficiency of Pharmaceutical Manufacturing Industry in China from 2007-2016 Based on Data Envelopment Analysis Model. Pharmaceutical Herald, 39, 1576-1587.
- Sun, H., & Yu, H. X. (2012). Research on Technological Innovation Efficiency and Innovation Capacity of Pharmaceutical Manufacturing Industry in Hebei Province. Science and Technology Management Research, 32, 85-90.
- Szabolcs, B., & Alvaro, E. (2010). Knowledge Spillovers in US Patents: A Dynamic Patent Intensity Model with Secret Common Innovation Factors. Journal of Econometrics, 159, 14-32. https://doi.org/10.1016/j.jeconom.2010.04.004
- Xu, M., & Hei, Q. M. (2020). Evaluation of Regional Competitiveness of China’s Pharmaceutical Industry. Statistics and Decision, 36, 73-76. https://doi.org/10.13546/j.cnki.tjyjc.2020.23.016
- Zeng, X., Li, X. J., & Wang, Z. H. (2018). Evaluation of Innovation Capability of Jiangsu Pharmaceutical Manufacturing Industry Based on Factor Analysis. Journal of Nanjing Medical University (Social Science Edition), 18, 17-20.
- Zhang, H. L. (2019). Research on Innovative Development Measures of China’s Biomedical Industry. Doctoral Thesis, Jilin University, Changchun, China. https://doi.org/10.27162/d.cnki.gjlin.2019.000329
- Zhang, J. Q., & Zhang, X. F. (2015). An Empirical Study on the Technological Innovation Capability of China’s Pharmaceutical Manufacturing Industry. Industrial Technology Economics, 34, 41-48.